DK3572090T3 - Korttidsvirkende faktor-vii-polypeptider - Google Patents

Korttidsvirkende faktor-vii-polypeptider Download PDF

Info

Publication number
DK3572090T3
DK3572090T3 DK19181784.0T DK19181784T DK3572090T3 DK 3572090 T3 DK3572090 T3 DK 3572090T3 DK 19181784 T DK19181784 T DK 19181784T DK 3572090 T3 DK3572090 T3 DK 3572090T3
Authority
DK
Denmark
Prior art keywords
short
acting factor
vii polypeptides
polypeptides
vii
Prior art date
Application number
DK19181784.0T
Other languages
English (en)
Inventor
Maxine Bauzon
Terry Hermiston
Original Assignee
Coagulant Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51022016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3572090(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Coagulant Therapeutics Corp filed Critical Coagulant Therapeutics Corp
Application granted granted Critical
Publication of DK3572090T3 publication Critical patent/DK3572090T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
DK19181784.0T 2012-12-24 2013-12-23 Korttidsvirkende faktor-vii-polypeptider DK3572090T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261745674P 2012-12-24 2012-12-24
US201361787026P 2013-03-15 2013-03-15
EP13867801.6A EP2938351B8 (en) 2012-12-24 2013-12-23 Short-acting factor vii polypeptides

Publications (1)

Publication Number Publication Date
DK3572090T3 true DK3572090T3 (da) 2023-01-09

Family

ID=51022016

Family Applications (3)

Application Number Title Priority Date Filing Date
DK13867801.6T DK2938351T3 (da) 2012-12-24 2013-12-23 Faktor vii-polypeptider med kortvarig virkning
DK16196780.7T DK3165232T3 (da) 2012-12-24 2013-12-23 Faktor vii-polypeptider med kortvarig virkning
DK19181784.0T DK3572090T3 (da) 2012-12-24 2013-12-23 Korttidsvirkende faktor-vii-polypeptider

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK13867801.6T DK2938351T3 (da) 2012-12-24 2013-12-23 Faktor vii-polypeptider med kortvarig virkning
DK16196780.7T DK3165232T3 (da) 2012-12-24 2013-12-23 Faktor vii-polypeptider med kortvarig virkning

Country Status (21)

Country Link
US (5) US20150344863A1 (da)
EP (3) EP3165232B1 (da)
JP (3) JP6566869B2 (da)
KR (2) KR102047235B1 (da)
CN (2) CN107099522A (da)
AU (2) AU2013370522B2 (da)
BR (1) BR112015015182B1 (da)
CA (2) CA2896057C (da)
DK (3) DK2938351T3 (da)
ES (3) ES2747726T3 (da)
HK (1) HK1216855A1 (da)
IL (2) IL239345B (da)
MX (2) MX2015007712A (da)
NZ (1) NZ708873A (da)
PE (2) PE20211303A1 (da)
PL (3) PL2938351T3 (da)
SA (1) SA517380867B1 (da)
SG (2) SG10201710593UA (da)
TW (3) TWI708783B (da)
WO (1) WO2014105784A1 (da)
ZA (1) ZA201505315B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013370522B2 (en) 2012-12-24 2019-01-17 Coagulant Therapeutics Corporation Short-acting Factor VII polypeptides
TW201629215A (zh) * 2014-09-30 2016-08-16 拜耳保健有限責任公司 使用凝血酶之組成物及治療方法
KR101755838B1 (ko) 2015-09-09 2017-07-07 현대자동차주식회사 엔진 예열장치 및 그 예열방법
JP2019530672A (ja) * 2016-09-13 2019-10-24 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ 第ｖｉｉａ因子グリコフォーム
KR102120921B1 (ko) * 2017-02-10 2020-06-10 주식회사 일리아스바이오로직스 Gba 단백질을 포함하는 엑소솜의 제조 방법 및 상기 제조 방법에 의해 제조된 엑소솜을 유효성분으로 함유하는 고셔병 예방 및 치료용 약학적 조성물
WO2021030787A1 (en) 2019-08-15 2021-02-18 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration and on-demand treatment

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3008252A (en) 1959-02-02 1961-11-14 Beatrice V Robinson Puffed sleeve ironer
US5180583A (en) 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
FR2632524B1 (fr) 1988-06-09 1992-03-13 Fondation Nale Transfusion San Procede de preparation d'une fraction concentree en facteur viia et son application a titre de medicament
PL206148B1 (pl) 2000-02-11 2010-07-30 Bayer HealthCare LLCBayer HealthCare LLC Koniugat polipeptydowy, polipeptyd, sekwencja nukleotydowa, wektor ekspresyjny, komórka gospodarz, sposób wytwarzania koniugatu polipeptydowego, środek farmaceutyczny i zastosowanie koniugatu polipeptydowego
DE60106763T2 (de) 2000-05-23 2006-01-26 Neurologix, Inc. Glutaminsäure decarboxylase (gad) abgabesystem zur behandlung neurodegeneraliver erkrankungen
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US20050221335A1 (en) 2001-12-14 2005-10-06 Anthony Kavanagh Reporter gene
PT1499719E (pt) * 2002-04-30 2011-02-09 Bayer Healthcare Llc Variantes polipeptídicas do factor vii ou viia
US8512710B2 (en) 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
JP4847856B2 (ja) * 2003-03-20 2011-12-28 バイエル ヘルスケア エルエルシー ＦＶＩＩおよびＦＶＩＩａの変種
PT1644504E (pt) * 2003-06-19 2010-03-22 Bayer Healthcare Llc Variantes do domínio gla dos factores vii ou viia
US20060198819A1 (en) * 2003-08-08 2006-09-07 Novo Nordisk Healthcare A/G Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
ES2381110T3 (es) * 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
EP1725673A1 (en) 2004-02-13 2006-11-29 Glycotope Gmbh Sialytated glycoproteins-process conditions and an efficient method for their production
EP1629096A1 (en) 2004-05-10 2006-03-01 BASF Plant Science GmbH Methods for assembling multiple expression constructs
JP2008503541A (ja) 2004-06-21 2008-02-07 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト グリコシル化分裂型因子ｖｉｉ変異体
US20100062973A1 (en) 2005-03-11 2010-03-11 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material
WO2006114105A2 (en) * 2005-04-26 2006-11-02 Maxygen Holdings Ltd. Use of modified factor vii for treating bleeding
US20070129298A1 (en) * 2005-07-22 2007-06-07 Maxygen Holdings, Ltd. In-solution activation of factor vii
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
AU2006280932A1 (en) * 2005-08-19 2007-02-22 Novo Nordisk A/S Glycopegylated factor VII and factor Vila
KR20080074166A (ko) * 2005-11-08 2008-08-12 아스테라스 세이야쿠 가부시키가이샤 혈소판감소증을 치료하는 조성물 및 방법
NZ572418A (en) * 2006-05-05 2011-08-26 Millennium Pharm Inc Factor xa inhibitors
FR2901707B1 (fr) 2006-05-31 2017-09-29 Lab Francais Du Fractionnement Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
US7532621B2 (en) 2006-08-30 2009-05-12 Cornell Research Foundation, Inc. Lateral error correction for time-critical multicast
US20100026939A1 (en) 2006-12-20 2010-02-04 Sumitomo Chemical Company, Limited Polarizer and liquid crystal display device
MX2009007139A (es) 2006-12-28 2009-10-08 Centocor Ortho Biotech Inc Metodos y vectores para generar inmunoglobulinas no sialiladas.
US8012733B2 (en) 2007-02-20 2011-09-06 Dsm Ip Assets B.V. Sialidases
AU2008245524A1 (en) 2007-04-26 2008-11-06 Cnj Holdings, Inc. Recombinant vitamin K dependent proteins with high sialic acid content and methods of preparing same
EP2930245B1 (en) 2007-10-12 2017-11-22 Sigma-Aldrich Co. LLC Cell line and methods for improved glycoprotein sialylation
TWI465247B (zh) * 2008-04-11 2014-12-21 Catalyst Biosciences Inc 經修飾的因子ｖｉｉ多肽和其用途
EP3225252A1 (en) * 2008-05-02 2017-10-04 Laboratoire Français du Fractionnement et des Biotechnologies Treatment of bleeding with low half-life fibrinogen
JP2010022253A (ja) * 2008-07-17 2010-02-04 Kaneka Corp アシアロ糖鎖化合物の作製方法
CA2776949A1 (en) 2008-12-05 2010-06-10 The Regents Of The University Of California Methods and compositions for treating p.acnes
US8400974B2 (en) * 2009-07-30 2013-03-19 Apple Inc. Methods and apparatus for providing dynamic information in a wireless information channel
US20130196410A1 (en) 2010-03-05 2013-08-01 Alnylam Pharmaceuticals, Inc Compositions and methods for modifying the glycosylation pattern of a polypeptide
WO2013017555A1 (en) * 2011-08-01 2013-02-07 Lfb-Biotechnologies Factor vii compositions with specific glycosylation for controlled half-life
AU2013370522B2 (en) 2012-12-24 2019-01-17 Coagulant Therapeutics Corporation Short-acting Factor VII polypeptides

Also Published As

Publication number Publication date
CN105025913A (zh) 2015-11-04
US10273466B2 (en) 2019-04-30
WO2014105784A1 (en) 2014-07-03
EP2938351A4 (en) 2016-08-24
US20150344863A1 (en) 2015-12-03
TWI708783B (zh) 2020-11-01
KR102111934B1 (ko) 2020-05-18
TW201920254A (zh) 2019-06-01
PL3165232T3 (pl) 2019-12-31
KR20150127573A (ko) 2015-11-17
TW201431876A (zh) 2014-08-16
HK1216855A1 (zh) 2016-12-09
SG11201504986QA (en) 2015-07-30
BR112015015182B1 (pt) 2023-12-26
US11530401B2 (en) 2022-12-20
EP3165232B1 (en) 2019-07-10
ZA201505315B (en) 2022-11-30
AU2013370522B2 (en) 2019-01-17
PL3572090T3 (pl) 2023-04-11
IL273559B (en) 2022-04-01
CA2896057C (en) 2023-03-14
EP2938351A1 (en) 2015-11-04
NZ708873A (en) 2019-11-29
PL2938351T3 (pl) 2020-03-31
JP2016507506A (ja) 2016-03-10
JP2017071608A (ja) 2017-04-13
AU2019202663B2 (en) 2020-09-10
AU2013370522A1 (en) 2015-07-09
SA517380867B1 (ar) 2020-06-10
TWI743542B (zh) 2021-10-21
CA3185756A1 (en) 2014-07-03
AU2013370522A2 (en) 2016-10-06
SG10201710593UA (en) 2018-02-27
AU2019202663A1 (en) 2019-05-09
KR20190072686A (ko) 2019-06-25
DK2938351T3 (da) 2019-09-23
KR102047235B1 (ko) 2019-11-22
EP2938351B1 (en) 2019-06-26
CN107099522A (zh) 2017-08-29
JP6363677B2 (ja) 2018-07-25
US20160376578A1 (en) 2016-12-29
US20140363419A1 (en) 2014-12-11
EP3572090B1 (en) 2022-12-14
NZ749488A (en) 2021-09-24
PE20151206A1 (es) 2015-09-04
EP2938351B8 (en) 2019-07-31
IL239345B (en) 2020-04-30
MX2015007712A (es) 2015-09-07
PE20211303A1 (es) 2021-07-20
JP2019213540A (ja) 2019-12-19
EP3572090A1 (en) 2019-11-27
EP3165232A1 (en) 2017-05-10
CA2896057A1 (en) 2014-07-03
ES2936485T3 (es) 2023-03-17
ES2747726T3 (es) 2020-03-11
IL273559A (en) 2020-05-31
JP6566869B2 (ja) 2019-08-28
TW202026309A (zh) 2020-07-16
BR112015015182A2 (pt) 2019-07-30
TWI681968B (zh) 2020-01-11
DK3165232T3 (da) 2019-09-16
MX2021002985A (es) 2021-05-14
IL239345A0 (en) 2015-07-30
US20210002624A1 (en) 2021-01-07
US10717970B2 (en) 2020-07-21
ES2746116T3 (es) 2020-03-04
US20230295596A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
DK2859055T3 (da) Polymercoatings
DK2825087T3 (da) Otoscanner
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2854722T3 (da) Stomipose
DK2825157T3 (da) Aminosyrelipider
DK2831122T3 (da) Anthocyanidin-kompleks
DK3572090T3 (da) Korttidsvirkende faktor-vii-polypeptider
DE112012006214T8 (de) Wulstringwickler
DE112012005566T8 (de) Seltenerdnanoverbundmagnet
FI20126082A (fi) Kaasunvaihtoventtiilijärjestely
DK2885638T3 (da) Molekylenet
DK2858657T3 (da) Feijoafrugtekstrakt
FI20126157A (fi) Laajentumistila
FI20125844A (fi) Talotekniikkamoduuli
ES1077590Y (es) Columbario
DE102013212400A8 (de) Abdeckplattenstützbaugruppe
FI20126108A (fi) Pankkorakenne
DK2897570T3 (da) Spin-elueringsrør
FI20126064A (fi) Leijupetilämmönvaihdin
ES1077210Y (es) Columbario cinerario
DE202012013401U8 (de) Bioextruder
FI20125436A (fi) Pienvenetelakka
DE102012100780A8 (de) Zugmittelhebevorrichtung